U.S., July 2 -- ClinicalTrials.gov registry received information related to the study (NCT07046611) titled 'Ketamine and Levetiracetam as Second-line Antiseizure Medication for Status Epilepticus in Children' on June 20.
Brief Summary: About 40% of children with generalized convulsive status epilepticus (GCSE) are not terminated by first-line benzodiazepines (BDZs), and approximately 50% of BDZ-refractory GCSE are not controlled by second-line antiseizure medications. This study investigates the efficacy of ketamine-levetiracetam combination vs. levetiracetam alone for treating children with BDZ-refractory GCSE.
Study Start Date: July 01
Study Type: INTERVENTIONAL
Condition:
Generalized Convulsive Status Epilepticus
Intervention:
DRU...